Tuesday, May 24, 2016 1:18:22 PM
http://investorshub.advfn.com/boards/replies.aspx?msg=122240532
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120345823&txt2find=evaluate
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=121375378&txt2find=AVII
http://investorshub.advfn.com/boards/replies.aspx?msg=122261567
http://investorshub.advfn.com/boards/replies.aspx?msg=122270840
The difference between us is that I see that the vaccine is contributing to overall survival. If the co-endpoint is not approved, then the study will have to prove a strong secondary endpoint of OS. Now that I know it uses the appropriate activation methods and avoids your freeze thaw concern, I can review prior results and see that they contributed to survival. What I need to wait for, just like everyone else, is whether the difference will be significant. I invested on a chance of that.
But to be clear I have not initiated a "buy"recommendation, at that level or any level since I started screaming "misleading" tendencies at the high . Even though you state that I did, you're wrong. You confuse my post of me trying to help people strategically add to dollar cost average. Me trying to convince Allie to sell didn't work. Me warning people not to buy, as they could lose it all. Me stating I sold out even the few shares I bought around the FR rule, and instead I only bought far out options as I couldn’t stand being long, and watching MGMT destroy the investment opportunity (the OS one I saw). Me telling folks even last month that $1.40 that more damage was in store, the shorts being in control.
http://investorshub.advfn.com/boards/replies.aspx?msg=122230122
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=122239178
And I've already proven to you that I foresaw these price levels in January. I actually referenced $.70s within my post back then.
Even now when I'm asked about this stock I let folks know how risky it is, and even suggest folks stay away. So bogus, I did not have this on my buy list. It represents a very risk buy, because no one knows how capital raises will work out. The company operates in secrecy. And they have misleading tendencies. I only bought shares based on the science. Recently, I came across the Regents agreement which proves when the INDs were written, and what patents are pertinent to this Phase III (a.k.a, activation methods are fine). That gave me a little more security in the science. And that made me want to have some shares as opposed to far out options. Where they do capital raises matters. And so I decided to get back in on a price that is the least risk. Taking my own advice, where I recommended that IF folks buy (as in add), that they do so where Woodford would, below $1. I continue to believe DCVax-L is helping patients live longer, OS. I continue to worry about PFS as an endpoint coming in short due to imaging standards. And this current SP takes into account depressive capital raises. And I continue to believe in the merits of testing the science. The price is at risk/reward entry levels, but that doesn't mean it can't drop if the silence continues. I just think that it will recover to these levels easily once any good news comes in.
http://investorshub.advfn.com/boards/replies.aspx?msg=119732727
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120165394
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120154754
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=121373258
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM